Yoshida H | National Hospital Organization Nagasaki Medical Center

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Case-control study for the identification of virological factors associated with fulminant hepatitis B
Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
Timing of interferon therapy and sources of infection in patients with acute hepatitis C
A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
Systemic Sclerosis Associated with Diabetes Insipidus
Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan
Serological Study of Bartonella henselae in Cat Scratch Disease in Japan
Relapsing Polychondritis Associated with Subclinical Sjogre's Syndrome and Phlegmon of the Neck
Protonation-Induced Conformational Changes of N,N,N',N'-Tetramethylethylenediamine. Importance of Strong N-H^+…N Hydrogen Bonding
Conformational Order of the Alkyl Chain in a Nonionic Surfactant α-Dodecyl-ω-hydroxytris (oxyethylene) (C_E_3) in Water
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C
Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

もっと見る

スポンサーリンク